These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 1648633

  • 1. A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.
    Yamada K, Saijo N, Kojima A, Ohe Y, Tamura T, Sasaki Y, Eguchi K, Shinkai T, Goya T, Kondou H.
    Jpn J Clin Oncol; 1991 Feb; 21(1):39-45. PubMed ID: 1648633
    [Abstract] [Full Text] [Related]

  • 2. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
    Shepherd FA, Ginsberg RJ, Patterson GA, Evans WK, Feld R.
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
    [Abstract] [Full Text] [Related]

  • 3. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
    Shepherd FA, Ginsberg RJ, Feld R, Evans WK, Johansen E.
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
    [Abstract] [Full Text] [Related]

  • 4. [Small cell lung carcinoma: role of thoracic irradiation and its timing in relation to chemotherapy].
    Payne DG, Murray N, Warde P.
    Bull Cancer; 1994 Feb; 81(2):119-28. PubMed ID: 7894117
    [Abstract] [Full Text] [Related]

  • 5. Cyclophosphamide, doxorubicin, and vincristine in etoposide- and cisplatin-resistant small cell lung cancer.
    Shepherd FA, Evans WK, MacCormick R, Feld R, Yau JC.
    Cancer Treat Rep; 1987 Oct; 71(10):941-4. PubMed ID: 2820571
    [Abstract] [Full Text] [Related]

  • 6. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 7. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T, Hiraki S, Ueoka H, Kawahara S, Numata T, Nishii K, Yonei T, Yamashta H, Kiura K, Kozuka A.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [Abstract] [Full Text] [Related]

  • 8. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Fetscher S, Hasse J, Frommhold H, Pressler K, Mertelsmann R, Engelhardt R, Kanz L.
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
    [Abstract] [Full Text] [Related]

  • 9. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 10. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 12. Surgical treatment of stage III lung cancer after chemotherapy and radiotherapy.
    Lee DY, Kim HK, Paik HC, Kim HJ, Kim SJ.
    Jpn J Clin Oncol; 1994 Apr 27; 24(2):101-5. PubMed ID: 8158856
    [Abstract] [Full Text] [Related]

  • 13. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 27; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 14. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May 27; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 15. Pilot study with weekly chemotherapy for patients with extensive small cell lung cancer: an Eastern Cooperative Oncology Group Study (PA586).
    Yuen AR, Fuks JZ, Ettinger DS, Chang AY, Ruckdeschel JC, Phan SC, Blum RH.
    Cancer J Sci Am; 2000 May 27; 6(1):34-9. PubMed ID: 10696737
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H, Kiura K, Tabata M, Kamei H, Gemba K, Sakae K, Hiraki Y, Hiraki S, Segawa Y, Harada M.
    Cancer; 1998 Jul 15; 83(2):283-90. PubMed ID: 9669811
    [Abstract] [Full Text] [Related]

  • 17. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D, Graziano F, Mari D, Cetto G, Pasini F, Antonio S, Isidori P, Gasparini S.
    Anticancer Res; 1994 Jul 15; 14(5B):2221-7. PubMed ID: 7840527
    [Abstract] [Full Text] [Related]

  • 18. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K, Wolf M, Drings P, Hans K, Schroeder M, Holle R, Flechtner H, Goerg R, Becker H.
    Semin Oncol; 1989 Feb 15; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [Abstract] [Full Text] [Related]

  • 19. Induction chemoradiotherapy followed by surgery for stage III non-small cell lung cancer.
    Yoneda S, Yamamoto M, Sakura M, Izumo T, Noguchi Y, Nishimura H, Sakai H, Gotoh I, Kobayashi K, Hayashi K.
    Jpn J Clin Oncol; 1993 Jun 15; 23(3):173-7. PubMed ID: 8394472
    [Abstract] [Full Text] [Related]

  • 20. [Induction chemotherapy followed by adjuvant surgery (IC-AS) in patients with stage I-II small cell lung cancer (SCLC)].
    Shibayama T, Hiyama J, Ueoka H, Tabata M, Segawa Y, Gemba K, Matsushita A, Ohnoshi T, Harada M, Andoh A.
    Gan To Kagaku Ryoho; 1995 Nov 15; 22(13):1953-8. PubMed ID: 7487126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.